Xtant Medical Holdings Inc (XTNT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Xtant Medical Holdings, Inc. (XTNT)
US:NASDAQ Investor Relations:
investor.xtantmedical.com
Company Research
Source: Yahoo! Finance
Licensing Revenue: $5.5 million included in Q3 2025 revenue. Biologics Revenue Growth: 4% increase over Q3 2024. Gross Margin: 66.1%, up from 58.4% in Q3 2024. Operating Expenses: $19.5 million, down from $20.1 million in Q3 2024. Net Income: $1.3 million or $0.01 per share, compared to a net loss of $5 million in Q3 2024. Adjusted EBITDA: $4.5 million, compared to a loss of $1 million in Q3 2024. Cash and Equivalents: $10.6 million as of September 30, 2025. Inventory: $40.7 million as of the end of the quarter. Warning! GuruFocus has detected 10 Warning Signs with XTNT. Is XTNT fairly valued? Test your thesis with our free DCF calculator. Release Date: November 11, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Xtant Medical Holdings Inc ( XTNT ) reported a 19% revenue growth over the third quarter of 2024, highlighting strong financial performance. The company generated positive ca
Show less
Read more
Impact Snapshot
Event Time:
XTNT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XTNT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XTNT alerts
High impacting Xtant Medical Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
XTNT
News
- Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft [Yahoo! Finance]Yahoo! Finance
- Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone GraftPR Newswire
- Companion Spine LLC Completes Acquisition of the Business and Assets of Paradigm Spine GmbH, including the Coflex® and CoFix® Spine Implants and All Other Implant Systems, from Xtant™ Medical Holdings, Inc. [Yahoo! Finance]Yahoo! Finance
- Companion Spine LLC Completes Acquisition of the Business and Assets of Paradigm Spine GmbH, including the Coflex® and CoFix® Spine Implants and All Other Implant Systems, from Xtant™ Medical Holdings, Inc.Business Wire
- Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion SpinePR Newswire
XTNT
Analyst Actions
- 11/11/25 - BTIG
XTNT
Sec Filings
- 1/16/26 - Form 4
- 1/16/26 - Form 8-K
- 12/3/25 - Form 8-K
- XTNT's page on the SEC website